Showing 1 - 5 of 5
Background: The Fracture Intervention Trial (FIT) showed that the bisphosphonate alendronate reduces the risk of fractures in women with low bone mass in the United States. Objective: To estimate the cost-effectiveness (cost per life-year gained and cost per quality-adjusted life-year, QALY,...
Persistent link: https://www.econbiz.de/10001673640
Persistent link: https://www.econbiz.de/10001693080
Persistent link: https://www.econbiz.de/10001435039
Persistent link: https://www.econbiz.de/10001464618
Persistent link: https://www.econbiz.de/10001474791